Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Joint effect of BSD-2000 system with NCI-endorsed cancer treatment being researched
February 23rd, 2006
BSD Medical Corp. (BSM) announced that the company is closely monitoring the U.S. National Cancer Institute's (NCI) recent endorsement of a method for treating ovarian cancer, because NCI's newly recommended treatment is currently being researched in combination with therapy provided by BSD's cancer treatment systems. The purpose of the research underway is to test the ability of BSD's cancer treatment systems to further improve the results from NCI's endorsed method of injecting chemotherapy drugs into the abdomen after surgery to increase the longevity of women suffering from ovarian cancer. The BSD-2000 cancer treatment system is designed to noninvasively focus heat...
Source: Women's Health Weekly (2006-02-23)
|
